Search Within

Katherine S Panageas

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (32)
  2. Meeting Abstract (18)
  3. Correspondence (2)
  4. Research Letter (2)
Groups
  1. Biostatistics Service (54)
  2. Epidemiology and Biostatistics (54)
  3. GSK Faculty (54)
  4. Human Oncology and Pathogenesis Program (54)
  5. Population Sciences Research Program (54)
  6. Department of Medicine (32)

More Groups

People
  1. Ingo Mellinghoff (19)
  2. Lisa De Angelis (18)
  3. Nikolaus Schultz (15)
  4. Anne Reiner (14)
  5. Thomas Kaley (14)
  6. Christian Grommes (12)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (6)
  6. 2020 (4)

More Years

Publications
  1. Neuro-Oncology (12)
  2. Clinical Cancer Research (9)
  3. Journal of Clinical Oncology (5)
  4. Cancer Research (4)
  5. Blood (2)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. Oxford University Press (14)
  3. American Society of Clinical Oncology (8)
  4. American Medical Association (2)
  5. American Society of Hematology (2)
  6. Cell Press (2)

More Publishers

Results (54)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma
    Meeting Abstract

    Omuro, A.; Beal, K.; Correa, D.; Chan, T.; DeAngelis, L.; Gavrilovic, I.; Nolan, C.; Hormigo, A.; Lassman, A. B.; Kaley, T.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
    Journal Article

    Nakahara, T.; Uchi, H.; Lesokhin, A. M.; Avogadri, F.; Rizzuto, G. A.; Hirschhorn-Cymerman, D.; Panageas, K. S.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
    Blood (2010)

    Fulltext@MSK | Save
  • Self-antigen-specifc CD8(+) T cell precursor frequency determines the quality of the antitumor immune response
    Journal Article

    Rizzuto, G. A.; Merghoub, T.; Hirschhorn-Cymerman, D.; Liu, C.; Lesokhin, A. M.; Sahawneh, D.; Zhong, H.; Panageas, K. S.; Perales, M. A.; Altan-Bonnet, G.; more...
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save
  • Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma
    Journal Article

    Solit, D. B.; Osman, I.; Polsky, D.; Panageas, K. S.; Daud, A.; Goydos, J. S.; Teitcher, J.; Wolchok, J. D.; Joseph Germino, F.; Krown, S. E.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save